Sittner & Nelson’s DexCom DXCM Stock Holding History

Sittner & Nelson’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43	Closed	-$4.01K	–	467
2023 Q3	$4.01K	Hold	43	–	–	﹤0.01%	399
2023 Q2	$5.53K	Buy	+43	New	+$5.2K	﹤0.01%	393

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sittner & Nelson's DXCM Position: Q4 2023 in Review

Sittner & Nelson sold out of DexCom (DXCM) in Q4 2023, closing a stake of 43 shares — an estimated $4.01K sold.

Sittner & Nelson first reported a position in DXCM in Q2 2023 and held it in 2 quarters. The position peaked at $5.53K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Sittner & Nelson reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Sittner & Nelson sold 43 DexCom shares in Q4 2023, an estimated $4.01K.
Sittner & Nelson first reported a position in DexCom in Q2 2023 and held it in 2 quarters.
Sittner & Nelson's DexCom position peaked at $5.53K in Q2 2023.
974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Sittner & Nelson's 13F filing for Q4 2023, filed 13 Feb 2024.